NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients

Background: Blood-based parameters are gaining increasing interest as potential prognostic biomarkers in patients with diffuse large B-cell lymphoma (DLBCL). The aim of this study was to comprehensively evaluate the prognostic significance of pretreatment plasma uric acid levels in patients with new...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2016-11, Vol.115 (10), p.1264-1272
Hauptverfasser:	Prochazka, Katharina T, Melchardt, Thomas, Posch, Florian, Schlick, Konstantin, Deutsch, Alexander, Beham-Schmid, Christine, Weiss, Lukas, Gary, Thomas, Neureiter, Daniel, Klieser, Eckhard, Greil, Richard, Neumeister, Peter, Egle, Alexander, Pichler, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/409 692/53/2422 692/699/67/1990/291/1621/1915 692/700/139 Adult Aged Antineoplastic Agents - therapeutic use Austria Biomarkers, Tumor - blood Biomedical and Life Sciences Biomedicine Cancer Research Disease Disease-Free Survival Drug Resistance Epidemiology Female Hematology Humans Immunotherapy - methods Internal medicine Kaplan-Meier Estimate Laboratories Lymphoma Lymphoma, Large B-Cell, Diffuse - blood Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - pathology Male Medical prognosis Medical research Middle Aged Molecular Medicine molecular-diagnostics Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - pathology Oncology Pathology Patients Prognosis Proportional Hazards Models Retrospective Studies Rituximab - therapeutic use Uric acid Uric Acid - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!